Menu
Back to User profile » Dr Arooj Mohsin Alvi
Papers published by Dr Arooj Mohsin Alvi:
Neuroprotective Effects of Melatonin and Celecoxib against Ethanol-Induced Neurodegeneration: A Computational and Pharmacological Approach [Corrigendum]
Al Kury LT, Zeb A, Abidin ZU, Irshad N, Malik I, Alvi AM, Khalil AAK, Ahmad S, Faheem M, Khan AU, Shah FA, Li S
Drug Design, Development and Therapy 2023, 17:2931-2932
Published Date: 22 September 2023
Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats [Retraction]
Zulfiqar Z, Shah FA, Shafique S, Alattar A, Ali T, Alvi AM, Rashid S, Li S
Journal of Inflammation Research 2022, 15:6069-6070
Published Date: 7 November 2022
1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating Nrf2-Pathway [Retraction]
Alvi AM, Shah FA, Muhammad AJ, Feng J, Li S
Journal of Inflammation Research 2022, 15:6013-6014
Published Date: 31 October 2022
RETRACTED ARTICLE: 1,3,4, Oxadiazole Compound A3 Provides Robust Protection Against PTZ-Induced Neuroinflammation and Oxidative Stress by Regulating Nrf2-Pathway
Alvi AM, Shah FA, Muhammad AJ, Feng J, Li S
Journal of Inflammation Research 2021, 14:7393-7409
Published Date: 29 December 2021
RETRACTED ARTICLE: Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats
Zulfiqar Z, Shah FA, Shafique S, Alattar A, Ali T, Alvi AM, Rashid S, Li S
Journal of Inflammation Research 2020, 13:1185-1205
Published Date: 24 December 2020
Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach
Al Kury LT, Zeb A, Abidin ZU, Irshad N, Malik I, Alvi AM, Khalil AAK, Ahmad S, Faheem M, Khan AU, Shah FA, Li S
Drug Design, Development and Therapy 2019, 13:2715-2727
Published Date: 2 August 2019